...
首页> 外文期刊>British Journal of Pharmacology >The contribution of adrenoceptor subtype(s) in the renal vasculature of diabetic spontaneously hypertensive rats
【24h】

The contribution of adrenoceptor subtype(s) in the renal vasculature of diabetic spontaneously hypertensive rats

机译:肾上腺素受体亚型在糖尿病自发性高血压大鼠肾血管中的作用

获取原文
获取原文并翻译 | 示例
           

摘要

1 Diabetes and hypertension are both associated with an increased risk of renal disease and are associated with neuropathies, which can cause defective autonomic control of major organs including the kidney. This study aimed to examine the α_1-adrenoceptor subtype(s) involved in mediating adrenergically induced renal vasoconstriction in a rat model of diabetes and hypertension. 2 Male spontaneously hypertensive rats (SHR), 220-280 g, were anaesthetized with sodium pentobarbitone 7-day poststreptozotocin (55 mg kg~(-1) i.p.) treatment. The reductions in renal blood flow (RBF) induced by increasing frequencies of electrical renal nerve stimulation (RNS), close intrarenal bolus doses of noradrenaline (NA), phenylephrine (PE) or methoxamine were determined before and after administration of nitrendipine (Nit), 5-methylurapidil (5-MeU), chloroethylclonidine (CEC) and BMY 7378. 3 In the nondiabetic SHR group, mean arterial pressure (MAP) was 146 ± 6mmHg, RBF was 28.0±1.4 ml min~(-1)kg~(-1) and blood glucose was 112.3±4.7mg dl~(-1), and in the diabetic SHR Group, MAP was 144 ± 3 mmHg, RBF 26.9±1.3 ml~(-1) min kg~(-1) and blood glucose 316.2± 10.5 mg dl~(-1). Nit, 5-MeU and BMY 7378 blunted all the adrenergically induced renal vasoconstrictor responses in SHR and diabetic SHR by 25-35% (all P< 0.05), but in diabetic rats the responses induced by RNS and NA treated with 5-MeU were not changed. By contrast, during the administration of CEC, vasoconstrictor responses to all agonists were enhanced by 20-25% (all P< 0.05) in both the SHR and diabetic SHR. 4 These findings suggest that α_(1A) and α_(1D)-adrenoceptor subtypes contribute in mediating the adrenergically induced constriction of the renal vasculature in both the SHR and diabetic SHR. There was also an indication of a greater contribution of presynaptic adrenoceptors, that is, α_(1B~-), and/or α_2-subtypes.
机译:1糖尿病和高血压都与肾脏疾病的风险增加相关,并且与神经病有关,神经病可以导致包括肾脏在内的主要器官的自主控制能力下降。这项研究旨在检查在糖尿病和高血压大鼠模型中介导肾上腺素能诱导的肾血管收缩的α_1-肾上腺素受体亚型。 2只雄性自发性高血压大鼠(SHR)220-280 g,用戊巴比妥钠链脲佐菌素治疗后7天(腹膜内注射55 mg kg〜(-1))麻醉。在服用尼群地平(Nit)之前和之后,确定由电肾神经电刺激(RNS)频率增加,肾内推注剂量的去甲肾上腺素(NA),去氧肾上腺素(PE)或甲氧胺引起的肾血流量(RBF)降低, 5-甲基尿嘧啶(5-MeU),氯乙基可乐定(CEC)和BMY 7378. 3在非糖尿病SHR组中,平均动脉压(MAP)为146±6mmHg,RBF为28.0±1.4 ml min〜(-1)kg〜( -1)和血糖为112.3±4.7mg dl〜(-1),而糖尿病SHR组的MAP为144±3 mmHg,RBF 26.9±1.3 ml〜(-1)min kg〜(-1)和血糖316.2±10.5 mg dl〜(-1)。 Nit,5-MeU和BMY 7378使SHR和糖尿病SHR中所有肾上腺素能诱导的肾血管收缩反应减弱25-35%(均P <0.05),但在糖尿病大鼠中,RNS和NA联合5-MeU诱导的反应为没有改变。相比之下,在给予CEC的过程中,SHR和糖尿病SHR对所有激动剂的血管收缩反应均提高了20-25%(所有P <0.05)。 4这些发现表明,α_(1A)和α_(1D)-肾上腺素受体亚型在介导肾上腺素能诱导的SHR和糖尿病SHR中肾血管的收缩中起作用。也有迹象表明突触前肾上腺素受体α_(1B〜-)和/或α_2-亚型的贡献更大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号